Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
Effect of Hyperemesis Gravidarum on 75 Gram Oral Glucose Tolerance Test Screening and Gestational Diabetes Mellitus
1 other identifier
observational
560
0 countries
N/A
Brief Summary
Hyperemesis gravidarum (HEG) is not only nausea and vomiting of pregnancy, but it is also a clinical syndrome including endocrine and metabolic complications. Recently, some investigators have been begun performing researches related to the development of gestational diabetes mellitus (GDM) in pregnant women with HEG because they think about those metabolic and endocrine complications of HEG.In the literature there are few studies assessing how HEG has effects on GDM or 75 gram oral glucose tolerance test (OGTT). So the investigators aim to evaluate the effects of HEG on 75 gram OGTT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 10, 2016
CompletedFirst Posted
Study publicly available on registry
November 15, 2016
CompletedApril 13, 2017
April 1, 2017
10 months
November 10, 2016
April 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine serum glucose levels in both groups during 75 gram oral glucose tolerance test screening
3 months
Study Arms (2)
hyperemesis gravidarum group
The study group consisted of women hospitalized for hyperemesis during first trimester of their pregnancy
the control group
whereas the control group included all other women who delivered in the same period.
Eligibility Criteria
This study was carried out with two groups. The study group consisted of women hospitalized for HEG during first trimester of their pregnancy, whereas the control group included all other women who delivered in the same period. When the pregnant women had those symptoms such as the presence of intractable vomiting during pregnancy associated with dehydration, electrolyte,and/or metabolic disturbances, as well as a weight loss 5% or more, they were diagnosed as HEG.
You may qualify if:
- between 18 and 35 years-old singleton pregnancies and performed 75 gram OGTT
You may not qualify if:
- Other causes lead to nausea and vomiting in pregnancy such as gastroenteritis, gastroparesis, hepatitis, intestinal obstruction, peptic ulcer, appendicitis, pyelonephritis, urolithiasis, ovarian torsion, diabetes mellitus, hyperthyroidism, hyperparathyroidism, migraine.
- And also patients who have risks for GDM such as body mass index \> 30, history of GDM in previous pregnancy and diabetes in the family were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YUSUF MADENDAG
Kayseri Education and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 10, 2016
First Posted
November 15, 2016
Study Start
January 1, 2016
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
April 13, 2017
Record last verified: 2017-04